On April 25 th Actavis Totowa initiating a Class I national recall of Digitek, a drug used to treat heart failure and abnormal heart rhythms. The drugs labeled under “UDK” by UDL Laboratories and under “Bertek” by Mylan Pharmaceuticals, Inc. The drugs are being recalled due to the possibility that tablets with double the appropriate thickness may contain twice the approved level of the active ingredient.
By ingesting twice the approved dose of active ingredient in Digitek, patients with renal failure are exposed to the risk of digitalis toxicity. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia.
Several patients have reported illness and injuries reportedly associated to Digitek. Exposed patients are advised to “DO NOT DISCONTINUE ANY MEDICATION” with out first consulting your doctor.
If you are a Digitek patient and would like to learn more about your legal options, please complete our Free Case Evaluation on this website.
Also, it’s been widely reported that there has been little to no consumer advertising from the manufacturers and distributors of Digitek.
FACTS ABOUT DIGITEK
- Digitek is a widely mail-ordered drug and is also provided in large scale retain chains like Walmart, Target and Costco
- Digitek is the biggest seller to treat congestive heart failure in pets.
- The drug has also been branded under Cardoxin, Digitek, Lanoxicaps, Lanoxin
- According to the manufacturer 11 adverse reaction cases have been reported.
- According to the US Department of Health and Human Services, Actavis Totowa was warned by HHS after an FDA inspection that took place in the summer of 2006.